These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 37844121)

  • 21. Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis.
    Tanaka A; Hirohara J; Nakano T; Matsumoto K; Chazouillères O; Takikawa H; Hansen BE; Carrat F; Corpechot C
    J Hepatol; 2021 Sep; 75(3):565-571. PubMed ID: 33882268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activation and hypercoagulability in patients with early primary biliary cholangitis compared with healthy controls.
    Vlachogiannakos J; Binas J; Siakavellas S; Karagiannakis DS; Voulgaris T; Papatheodoridis GV; Ladas SD
    Ann Gastroenterol; 2021; 34(2):229-234. PubMed ID: 33654364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD19
    Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
    Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort.
    Marschall HU; Henriksson I; Lindberg S; Söderdahl F; Thuresson M; Wahlin S; Ludvigsson JF
    Sci Rep; 2019 Aug; 9(1):11525. PubMed ID: 31395896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Contribution of B Cells in Autoimmune Liver Diseases.
    Taylor SA; Assis DN; Mack CL
    Semin Liver Dis; 2019 Nov; 39(4):422-431. PubMed ID: 31226726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases.
    Ostrowski J; Goryca K; Lazowska I; Rogowska A; Paziewska A; Dabrowska M; Ambrozkiewicz F; Karczmarski J; Balabas A; Kluska A; Piatkowska M; Zeber-Lubecka N; Kulecka M; Habior A; Mikula M; ;
    Sci Rep; 2019 May; 9(1):7190. PubMed ID: 31076612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.
    Onofrio FQ; Hirschfield GM; Gulamhusein AF
    Gastroenterol Hepatol (N Y); 2019 Mar; 15(3):145-154. PubMed ID: 31061656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms.
    Bombaci M; Pesce E; Torri A; Carpi D; Crosti M; Lanzafame M; Cordiglieri C; Sinisi A; Moro M; Bernuzzi F; Gerussi A; Geginat J; Muratori L; Terracciano LM; Invernizzi P; Abrignani S; Grifantini R
    Liver Int; 2019 Nov; 39(11):2124-2135. PubMed ID: 31033124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological abnormalities in patients with primary biliary cholangitis.
    Ma WT; Chen DK
    Clin Sci (Lond); 2019 Mar; 133(6):741-760. PubMed ID: 30890652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data.
    Doncheva NT; Morris JH; Gorodkin J; Jensen LJ
    J Proteome Res; 2019 Feb; 18(2):623-632. PubMed ID: 30450911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and Management of Primary Biliary Cholangitis.
    Younossi ZM; Bernstein D; Shiffman ML; Kwo P; Kim WR; Kowdley KV; Jacobson IM
    Am J Gastroenterol; 2019 Jan; 114(1):48-63. PubMed ID: 30429590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis in primary biliary cholangitis.
    Danford CJ; Trivedi HD; Papamichael K; Tapper EB; Bonder A
    World J Gastroenterol; 2018 Aug; 24(31):3513-3520. PubMed ID: 30131657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.
    Sato K; Marzioni M; Meng F; Francis H; Glaser S; Alpini G
    Hepatology; 2019 Jan; 69(1):420-430. PubMed ID: 30070383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases.
    Lindor KD; Bowlus CL; Boyer J; Levy C; Mayo M
    Hepatology; 2019 Jan; 69(1):394-419. PubMed ID: 30070375
    [No Abstract]   [Full Text] [Related]  

  • 35. Biomarkers for primary biliary cholangitis: current perspectives.
    Kouroumalis E; Samonakis D; Voumvouraki A
    Hepat Med; 2018; 10():43-53. PubMed ID: 29950909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    Liao CY; Chung CH; Chu P; Wei KY; Feng TM; Lin FH; Tsao CH; Wu CC; Chien WC
    PLoS One; 2018; 13(3):e0194418. PubMed ID: 29543880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis.
    Asghar K; Brain J; Palmer JM; Douglass S; Naemi FMA; O'Boyle G; Kirby J; Ali S
    Oncol Lett; 2017 Nov; 14(5):5497-5504. PubMed ID: 29113177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered B cell signalling in autoimmunity.
    Rawlings DJ; Metzler G; Wray-Dutra M; Jackson SW
    Nat Rev Immunol; 2017 Jul; 17(7):421-436. PubMed ID: 28393923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Molecular Stratification of High-risk Primary Biliary Cholangitis.
    Hardie C; Green K; Jopson L; Millar B; Innes B; Pagan S; Tiniakos D; Dyson J; Haniffa M; Bigley V; Jones DE; Brain J; Walker LJ
    EBioMedicine; 2016 Dec; 14():65-73. PubMed ID: 27913155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.